Summary: Researchers have genetically engineered a clone of the Zika virus strain. They believe the development could expedite research of the disease.Source: UTMB Galveston.The Zika virus infectious clone is key to rapid vaccine development and unraveling the mysteries of why the Zika virus causes the recent explosive epidemics and birth defects and disease.A multidisciplinary team from The University of Texas Medical Branch at Galveston is the first in the world to genetically engineer a clone of the Zika virus strain, a development that could expedite many aspects of Zika research, including vaccine and therapeutics development.Cloning the virus unlocks scientists’ ability to more quickly develop countermeasures and explore whether or how the Zika virus has evolved to spread more quickly and cause more severe diseases in people. This study is now available in Cell Host and Microbe.“The new Zika clone, together with mosquito infection models and the UTMB-developed Zika mouse model, represent a major advance towards deciphering why the virus is tied to serious diseases,” said lead author Pei-Yong Shi, UTMB endowed professor. “The new clone is also a critical step in developing a vaccine and antiviral drug against Zika.”For 60 years, the Zika virus remained obscure with few identified cases in people and mild disease symptoms. However, since 2007, the virus has sparked frequent epidemics associated with serious diseases such as microcephaly and Guillain-Barre syndrome.The researchers first constructed the Zika virus clone. Five fragments spanning the complete viral genome were individually cloned and assembled into the full-length clone of the Zika virus.The infectious cDNA clone allows researchers to make Zika virus from test tube and cells on petri dishes. The researchers then used the UTMB-developed Zika mouse model to demonstrate that the cloned virus infected the mice and gave them neurological disease.The team fed Aedes aegypti mosquitoes, one of the mosquito types known to transmit Zika, with human blood infected with either the parental Zika virus or the “man-made” Zika virus and found that the number of infected mosquitoes was similar. These findings confirm that the cloned virus is highly infectious for Aedes aegypti mosquitoes. In addition, the results demonstrated that Aedes aegypti might be a good mosquito vector for Zika virus transmission.Furthermore, the team engineered a luciferase reporter Zika virus. Luciferase is the chemical in fireflies that gives them their signature glow. The “glowing” reporter virus could be used for antiviral drug screening. In addition, the reporter signal could be used to track Zika virus infection in mosquitoes and small animal models.There are a number of possible factors that may account for the current Zika virus epidemic that can now be tested with the UTMB clone. For instance, the Zika virus may have evolved in a way that enhances mosquito transmission, leading to it spreading much more quickly. This idea could be tested by comparing how infectious the original Zika strains are to mosquitos with current strains, followed by manipulating the clone to test the effects of recent mutations on mosquito transmission.The researchers first constructed the Zika virus clone. Five fragments spanning the complete viral genome were individually cloned and assembled into the full-length clone of the Zika virus. NeuroscienceNews.com image is for illustrative purposes only.It is possible that the Zika virus has adapted to maintain higher virus concentrations in peoples’ blood, making it easier to cross the placenta and cause microcephaly. This possibility could be ruled out or confirmed by engineering mutant Zika viruses and testing out the effects on Zika mice.“This is a good example of collaboration among different teams on UTMB campus. I joined UTMB about six months ago. Without collaborating with great colleagues, we would not be able to report such a comprehensive data package in the study,” said Shi. “In fact, many experiments were performed in Mariano Garcia-Blanco and Shelton Bradricks’ laboratories because my equipment had not yet fully arrived.”[divider]About this genetics research article[/divider]Other authors include UTMB’s Chao Shan, Xuping Xie, Antonio Muruato, Shannan Rossi, Christopher Roundy, Sasha Azar, Yujiao Yang, Robert Tesh, Nigel Bourne, Alan Barrett, Nikos Vasilakis and Scott Weaver.Funding: This research was supported by NIH grants AI120942 and AI087856.Source: Donna Ramirez – UTMB Galveston Image Source: This NeuroscienceNews.com image is in the public domain. Original Research: Full open access research for “An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors” by Chao Shan, Xuping Xie, Antonio E. Muruato, Shannan L. Rossi, Christopher M. Roundy, Sasha R. Azar, Yujiao Yang, Robert B. Tesh, Nigel Bourne, Alan D. Barrett, Nikos Vasilakis, Scott C. Weaver, and Pei-Yong Shi in Cell Host & Microbe. Published online May 16 2016 doi:10.1016/j.chom.2016.05.004See alsoFeaturedNeuroscience·June 2, 2020Estrogen’s role in the sex differences of alcohol abuse[divider]Cite This NeuroscienceNews.com Article[/divider][cbtabs][cbtab title=”MLA”]UTMB Galveston. “Researchers Genetically Engineer Zika Virus Infectious cDNA Clone.” NeuroscienceNews. NeuroscienceNews, 16 May 2016. <https://neurosciencenews.com/cdna-genetics-zika-4230/>.[/cbtab][cbtab title=”APA”]UTMB Galveston. (2016, May 16). Researchers Genetically Engineer Zika Virus Infectious cDNA Clone. NeuroscienceNews. Retrieved May 16, 2016 from https://neurosciencenews.com/cdna-genetics-zika-4230/[/cbtab][cbtab title=”Chicago”]UTMB Galveston. “Researchers Genetically Engineer Zika Virus Infectious cDNA Clone.” https://neurosciencenews.com/cdna-genetics-zika-4230/ (accessed May 16, 2016).[/cbtab][/cbtabs]AbstractAn Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral InhibitorsHighlights •An infectious cDNA clone of Zika virus and a luciferase reporter virus were developed •Recombinant Zika virus is virulent in A129 and AG129 mice •Recombinant Zika virus is highly infectious for Aedes aegypti mosquitos •The luciferase Zika virus can be used for antiviral drug discoverySummary The Asian lineage of Zika virus (ZIKV) has recently caused epidemics and severe disease. Unraveling the mechanisms causing increased viral transmissibility and disease severity requires experimental systems. We report an infectious cDNA clone of ZIKV that was generated using a clinical isolate of the Asian lineage. The cDNA clone-derived RNA is infectious in cells, generating recombinant ZIKV. The recombinant virus is virulent in established ZIKV mouse models, leading to neurological signs relevant to human disease. Additionally, recombinant ZIKV is infectious for Aedes aegypti and thus provides a means to examine virus transmission. The infectious cDNA clone was further used to generate a luciferase ZIKV that exhibited sensitivity to a panflavivirus inhibitor, highlighting its potential utility for antiviral screening. This ZIKV reverse genetic system, together with mouse and mosquito infection models, may help identify viral determinants of human virulence and mosquito transmission as well as inform vaccine and therapeutic strategies.“An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors” by Chao Shan, Xuping Xie, Antonio E. Muruato, Shannan L. Rossi, Christopher M. Roundy, Sasha R. Azar, Yujiao Yang, Robert B. Tesh, Nigel Bourne, Alan D. Barrett, Nikos Vasilakis, Scott C. Weaver, and Pei-Yong Shi in Cell Host & Microbe. Published online May 16 2016 doi:10.1016/j.chom.2016.05.004[divider]Feel free to share this Neuroscience News.[/divider]Join our Newsletter I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )Sign up to receive the latest neuroscience headlines and summaries sent to your email daily from NeuroscienceNews.comWe hate spam and only use your email to contact you about newsletters. We do not sell email addresses. You can cancel your subscription any time.